Cognitive memory screening and referral program in community pharmacies in the United States
Open Access
- 20 December 2013
- journal article
- research article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 36 (2) , 360-367
Abstract
Introduction 12 chain community pharmacy sites located in two geographic areas with the United States implemented easy-to-administer memory screening assessments for patients with risk factors of cognitive memory decline and referred at-risk patients to their physicians. Aim of the study To evaluate the impact of a pharmacy-based cognitive memory screening and referral program, measure patient satisfaction with these advanced clinical services, and assess willingness to pay for cognitive memory screening services. Setting 12 chain pharmacy sites located in two geographic areas—ten Fred Meyer Pharmacies located in the Portland, Oregon area and two Kerr Drug Pharmacies located in North Carolina. Method Pharmacists were educated on Alzheimer’s disease, trained on how to provide cognitive memory screening exams, and equipped with screening and documentation tools. Following each screening, pharmacist provided education and counseling to the patients and referred at-risk patients to physicians for follow-up as appropriate. Main outcome measures Results of screenings; satisfaction of patients; willingness to pay. Results Pharmacists delivered cognitive memory assessments to 161 patients from June to November 2008. 44.1 % of patients experienced at least one cognitive deficiency that required referral to a physician based on the screening conducted. The cognitive memory screening and referral program was highly regarded by patients who completed the satisfaction survey, with 98.4 % of respondents indicating that they were either very satisfied or satisfied with the program. Conclusion Cognitive memory screening can be easily incorporated into clinical service offerings in community pharmacy practice and provides a valuable opportunity to identify patients at-risk and refer them to a physician for appropriate testing and diagnosis.Keywords
This publication has 23 references indexed in Scilit:
- Community-based intervention to promote breast cancer awareness and screening: The Korean experienceBMC Public Health, 2011
- Screening for pre-hypertension and elevated cardiovascular risk factors in a Thai community pharmacyPharmacy World & Science, 2010
- Association of higher diastolic blood pressure levels with cognitive impairmentNeurology, 2009
- Brain structure and obesityHuman Brain Mapping, 2009
- Midlife Serum Cholesterol and Increased Risk of Alzheimer’s and Vascular Dementia Three Decades LaterDementia and Geriatric Cognitive Disorders, 2009
- The brain in the age of old: The hippocampal formation is targeted differentially by diseases of late lifeAnnals of Neurology, 2008
- Central obesity and increased risk of dementia more than three decades laterNeurology, 2008
- Screening for sleep disorders in community pharmacies - evaluation of a campaign in SwitzerlandJournal of Clinical Pharmacy and Therapeutics, 2006
- Validation of a Brief Screen for Cognitive Impairment (BSCI) Administered by Telephone for Use in the Medicare PopulationDisease Management, 2005
- Diagnostic utility of abbreviated fluency measures in Alzheimer disease and vascular dementiaNeurology, 2004